Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Agios Pharmaceuticals Inc. (AGIO)

40.94   0.86 (2.15%) 12-06 16:00
Open: 40.41 Pre. Close: 40.08
High: 40.96 Low: 39.925
Volume: 590,969 Market Cap: 2799M
Agios Pharmaceuticals Inc is a biopharmaceutical company which focuses on developing treatments geared towards cancer and rare genetic disorders of metabolism. It also emphasizes on developing potentially transformative small-molecule medicines.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 40.99 - 41.184 41.184 - 41.367
Low: 39.421 - 39.645 39.645 - 39.856
Close: 40.57 - 40.924 40.924 - 41.256

Technical analysis

as of: 2019-12-06 4:32:24 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 47.84     One year: 55.88
Support: Support1: 34.32    Support2: 30.22
Resistance: Resistance1: 40.96    Resistance2: 47.84
Pivot: 38.21
Moving Average: MA(5): 39.82     MA(20): 37.08
MA(100): 37.58     MA(250): 47.65
MACD: MACD(12,26): 1.65     Signal(9): 1.31
Stochastic oscillator: %K(14,3): 96.95     %D(3): 95.54
RSI: RSI(14): 71.70
52-week: High: 68.94  Low: 28.36  Change(%): -22.3
Average Vol(K): 3-Month: 85355  10-Days: 79778

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AGIO has closed below upper band by 4.6%. Bollinger Bands are 8.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-11-15
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Major Shareholder Corp /De/ Celgene Purchases 403,225 Shares of Stock
Agios Pharmaceuticals Inc (NASDAQ:AGIO) major shareholder Corp /De/ Celgene acquired 403,225 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The shares were purchased at an average cost of $31.00 per share, for a total transaction of $12,499,975.00. Following the acquisition, the insider now owns 1,777,824 shares in the company, […]

2019-11-14
Insider Buying: Agios Pharmaceuticals Inc (NASDAQ:AGIO) Major Shareholder Acquires 403,225 Shares of Stock
Agios Pharmaceuticals Inc (NASDAQ:AGIO) major shareholder Corp /De/ Celgene bought 403,225 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was bought at an average price of $31.00 per share, for a total transaction of $12,499,975.00. Following the purchase, the insider now directly owns 1,777,824 shares of the company’s stock, […]

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 68.37
Shares Float (M) 52.18
% Held by Insiders 12.93
% Held by Institutions 102.15
Shares Short (K) 11500
Shares Short P. Month (K)

Stock Financials

EPS -6.850
Book Value (p.s.) 7.610
PEG Ratio -0.14
Profit Margin
Operating Margin -370.50
Return on Assets (ttm) -32.0
Return on Equity (ttm) -66.3
Qtrly Rev. Growth 71.2
Gross Profit (p.s.) -3.632
Sales Per Share
EBITDA (p.s.) -5.978
Qtrly Earnings Growth
Operating Cash Flow (M) -351.20
Levered Free Cash Flow (M) -197.62

Stock Valuations

P/E -5.98
P/E Growth Ratio 0.02
P/BV 5.38
P/S 21.32
P/CF -7.97

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.